Literature DB >> 25397872

What's in a name? Developing definitions for common health technology assessment product types of the International Network of Agencies for Health Technology Assessment (inahta).

Tracy Merlin1, David Tamblyn1, Benjamin Ellery1.   

Abstract

OBJECTIVES: A mapping exercise was undertaken to determine how HTA is being described and conducted across the International Network of Agencies for Health Technology Assessment (INAHTA), with the aim of harmonizing terminologies and approaches.
METHODS: Three progressive surveys were undertaken. In 2010, INAHTA agencies were asked to provide details on all of their HTA products. In 2013, additional information was sought on key methodological characteristics of five of the most common HTA product types. Subsequently, final agreement was sought on three proposed product types.
RESULTS: Forty-five HTA agencies responded to at least one of the surveys. In 2010, twenty-one agencies reported publishing over seventy named HTA products. Core domains associated with full HTA reports were reported by a third of agencies but were labeled differently, so products were classified according to product type (n = 17). Agencies producing short, tailored products increased between 2010 and 2013, with the publication of rapid reviews doubling from 33 percent to 66 percent. In 2013, half of the agencies adapted their common HTA products from documents produced by other agencies. A consensus (>70 percent) was achieved on definitions for HTA reports, mini-HTAs, and rapid reviews.
CONCLUSIONS: The product label for an HTA is not always indicative of its content. Terminology has, therefore, been agreed to make explicit the trade-off between rigor and timeliness in three common HTA product types. An INAHTA Product Type (IPT) Mark has been created to identify each of these. It is hoped this will further facilitate HTA adaptation between agencies and reduce duplication of effort.

Entities:  

Keywords:  Health Policy/standards

Mesh:

Year:  2014        PMID: 25397872     DOI: 10.1017/S0266462314000543

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  8 in total

1.  Expediting evidence synthesis for healthcare decision-making: exploring attitudes and perceptions towards rapid reviews using Q methodology.

Authors:  Shannon E Kelly; David Moher; Tammy J Clifford
Journal:  PeerJ       Date:  2016-10-06       Impact factor: 2.984

2.  Cochrane Rapid Reviews Methods Group to play a leading role in guiding the production of informed high-quality, timely research evidence syntheses.

Authors:  Chantelle Garritty; Adrienne Stevens; Gerald Gartlehner; Valerie King; Chris Kamel
Journal:  Syst Rev       Date:  2016-10-28

Review 3.  Health technology assessment of public health interventions: an analysis of characteristics and comparison of methods-study protocol.

Authors:  Tim Mathes; Gerald Willms; Stephanie Polus; Constance Stegbauer; Melanie Messer; Corinna Klingler; Heidi Ehrenreich; Dea Niebuhr; Georg Marckmann; Ansgar Gerhardus; Dawid Pieper
Journal:  Syst Rev       Date:  2018-05-23

4.  Methods for the health technology assessment of complex interventions: a protocol for a scoping review.

Authors:  Abdolvahab Baghbanian; Tracy Merlin; Drew Carter; Shuhong Wang
Journal:  BMJ Open       Date:  2020-11-30       Impact factor: 2.692

Review 5.  The Utility of a Rapid Review Evaluation Process to a National HTA Agency.

Authors:  Áine Varley; Lesley Tilson; Emer Fogarty; Laura McCullagh; Michael Barry
Journal:  Pharmacoeconomics       Date:  2021-10-12       Impact factor: 4.981

6.  Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.

Authors:  Tania Yuka Yuba; Hillegonda Maria Dutilh Novaes; Patrícia Coelho de Soárez
Journal:  Health Res Policy Syst       Date:  2018-05-11

Review 7.  Health technology assessment of biosimilars worldwide: a scoping review.

Authors:  Bruna de Oliveira Ascef; Ana Carolina de Freitas Lopes; Patrícia Coelho de Soárez
Journal:  Health Res Policy Syst       Date:  2020-08-26

8.  Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.

Authors:  Wija Oortwijn; Maarten Jansen; Rob Baltussen
Journal:  Int J Health Policy Manag       Date:  2020-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.